Is coronary microvascular dysfunction in the setting of chronic ischemia independent of arginase activity?
Coronary microvascular dysfunction in the setting of chronic myocardial ischemia occurs independently of Arginase I activity and expression. Alternative therapeutic strategies focusing away from arginine may be need for the treatment of this dysfunction.
Women with endocervical dyskaryosis or CGIN should be treated by LLETZ. Provided LLETZ is repeated in cases of incomplete endocervical CGIN excision cytological follow-up can take place in the community.